Trials / Completed
CompletedNCT02193035
Microparticles in Severe Aortic Stenosis
Microparticles as an Inflammatory Marker in Severe Aortic Stenosis.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- InCor Heart Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Microparticles are small cell fragments that can induce fat plaques, calcification and formation of thrombus. They can be released through multiple stimulations, but also the high flow of blood through partially obstructed aortic valves. In patients with severely obstructed aortic valves the investigators hypothesize that microparticles levels will be elevated and that they will go down after percutaneous treatment of the valves.
Detailed description
Microparticle (MPs) levels and subtypes according to endothelial cell, macrophage and platelet markers will be measured by flow-cytometry using appropriate fluorochromes. Patient baseline (including measures of severity of aortic stenosis and its calcification), procedural data, and clinical evolution will be collected. Inflammatory markers will be measured, which along with clinical date will be tested for correlation with microparticle levels. Patients MPs will be measured before and after percutaneous treatment of the severe aortic stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Microparticle levels | Microparticle levels will be evaluated with flow cytometry and nanoparticle tracking analysis |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2014-07-17
- Last updated
- 2016-04-13
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02193035. Inclusion in this directory is not an endorsement.